查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1584677

心臟 POC 測試設備市場：按產品類型、應用和最終用戶分類 - 2025-2030 年全球預測

Cardiac POC Testing Devices Market by Product (Cardiac Biomarker Test, Consumable & Accessories, Devices), Device Type (Bench-top POC Devices, Handheld POC Devices, Wearable POC Devices), Application, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年心臟POC測試設備市值為13.6億美元，預計2024年將達到15.2億美元，複合年成長率為12.36%，預計到2030年將達到30.8億美元。

心臟照護端 (POC) 測試設備是攜帶式醫療診斷工具，旨在直接在患者照護端快速準確地評估心臟標記物，而不是依賴中央測試設施。這些設備對於在緊急情況下提供快速測試結果並幫助醫療保健提供者及時做出決策（例如在急性心肌梗塞的情況下）至關重要。由於它易於使用且不依賴專門的檢測設施，因此可用於多種環境，包括醫院、診所、門診診所和居家醫療。市場成長主要受到心血管疾病盛行率上升、對快速診斷解決方案的需求不斷增加以及患者管理分散化的全球趨勢的影響。生物標記發現和微流體的創新正在推動該領域的技術進步，進一步擴大應用範圍，並為新參與企業和現有企業提供有利的機會。然而，挑戰仍然存在，包括嚴格的監管要求、高昂的設備成本以及非實驗室環境中的測試準確性和可靠性問題。亞太和拉丁美洲等醫療基礎設施需求快速成長的地區具有巨大的市場滲透和成長潛力。此外，專注於設備小型化和增強連接性（包括與醫療 IT 系統整合）的聯合研發工作，為實現差異化和市場領先地位提供了途徑。企業應利用數位健康趨勢，透過開發支援遠端醫療和遠端監控的連網型POC 解決方案來應對不斷發展的患者照護模式。創新的一個關鍵領域是增強 POC 設備上可用測試面板的可靠性和廣度，從而實現全面且更準確的心臟診斷。持續投資用於預測醫療保健的人工智慧主導分析可以進一步使公司在競爭格局中佔據優勢。

主要市場統計
基準年[2023] 13.6億美元
預測年份 [2024] 15.2億美元
預測年份 [2030] 30.8億美元
複合年成長率（%） 12.36%

市場動態：快速發展的心臟 POC 測試設備市場的關鍵市場洞察

供需的動態交互作用正在改變心臟 POC 測試設備市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 全球心臟病盛行率和老年人口增加
    • 傾向於早期發現和診斷患者
    • 政府對心臟健康的有利支持
  • 市場限制因素
    • 心臟POC檢測設備產品召回的潛在風險
  • 市場機會
    • 實施獨特的新型肌鈣蛋白測試
    • 積極的投資與新興企業生態系統
  • 市場挑戰
    • 有關心臟 POC 測試設備準確性的限制和擔憂

波特五力：引領心臟 POC 測試設備市場的策略工具

波特五力框架是了解心臟 POC 測試設備市場競爭格局的關鍵工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解心臟 POC 測試設備市場的外部影響

外部宏觀環境因素在塑造心臟 POC 測試設備市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助企業預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解心臟POC檢測設備市場競爭狀況

對心臟 POC 測試設備市場的詳細市場佔有率分析可以對供應商的業績進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣心臟 POC 測試設備市場供應商的績效評估

FPNV 定位矩陣是評估心臟 POC 測試設備市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議，以規劃心臟 POC 測試設備市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對心臟 POC 測試設備市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 全球心臟病盛行率和老年人口增加
      • 患者早期檢測和診斷的趨勢
      • 政府對心臟健康的有利支持
    • 抑制因素
      • 心臟 POC 測試設備產品召回的潛在風險
    • 機會
      • 推出獨特的新型肌鈣蛋白測試
      • 活躍的投資與Start-Ups生態系統
    • 任務
      • 有關心臟 POC 測試設備準確性的限制和擔憂
  • 市場區隔分析
    • 產品：各種心臟 POC 測試設備的監管核准
    • 設備類型：研究穿戴式POC設備，為心臟病管理提供便利的居家照護
    • 應用：有效的診斷和篩檢程序在心臟病管理中發揮的重要作用
    • 最終使用者：醫院為改善心臟健康提供廣泛而全面的護理
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章心臟POC測試設備市場：依產品

  • 心臟生物標記測試
    • B型利鈉胜肽
    • 肌酸激酶-MB [CK-MB] 組成
    • D-二聚體測試
    • 肌紅蛋白測試
    • 肌鈣蛋白測試
  • 耗材及配件
  • 裝置
    • 分析儀
    • 影像和監控設備

第7章心臟 POC 測試設備市場：依設備類型

  • 桌上型POC設備
  • 手持式POC設備
  • 穿戴式POC設備

第8章心臟 POC 測試設備市場：依應用分類

  • 診斷和篩檢
  • 監視

第9章心臟 POC 測試設備市場：依最終用戶分類

  • 門診手術中心
  • 診斷實驗室
  • 主頁設定
  • 醫院

第10章 北美及南美心臟POC測試設備市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太心臟POC測試設備市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東、非洲心臟POC檢測設備市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • 西門子 Healthineers 在 Atelica 平台上推出 NT-proBNPII 檢測，以增強心臟衰竭診斷並加速患者照護
    • F. Hoffmann La Roche AG 推出了帶有 Cobas H 232 的 NT-proBNP就地檢驗，以加強糖尿病患者 CVD 和心臟衰竭的早期檢測和管理。
    • Analytics for Life 和 CorVista Health 的非侵入性 CorVista 肺動脈高壓系統獲得 FDA 批准
    • Eko Health, Inc. 和 Mayo Clinic 獲得 FDA 批准進行基於人工智慧的低射血分數檢測
    • SpinChip Diagnostics 獲得生物梅里埃 1.15 億挪威克朗投資，用於下一代心臟 POC 測試設備的商業化
    • 羅氏收購 LumiraDx微流體照護現場技術以推進心血管診斷
    • Primary Health Tech 的 MobiLab 設備透過物聯網整合實現心臟病和慢性病的早期檢測
    • EDX Medical Group Plc. 收購 Hutano Diagnostics Ltd. 以開發先進的智慧型手機整合 POC 測試
    • EDX Medical Group 收購 Hutano Diagnostics，利用先進的診斷技術徹底改變快速醫療檢測，提高速度、準確性和成本效率
    • Cipla 透過 CE IVD核准擴大了其診斷產品組合，並推出了 cippoint，這是一種 POC 測試設備，以增強快速臨床決策和市場滲透。
  • 戰略分析和建議
    • F.霍夫曼羅氏有限公司
    • 西門子醫療集團
    • 雅培實驗室
    • 丹納赫公司
    • 韋爾芬, 南澳州

公司名單

  • Abbott Laboratories
  • ACON Laboratories, Inc.
  • Alfa Scientific Designs, Inc.
  • Bio-Rad Laboratories, Inc.
  • Cipla Limited
  • Compagnie Merieux Alliance SAS
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd
  • Getein Biotech, Inc.
  • Laboratory Corporation of America Holdings
  • LifeSign LLC
  • Medtronic plc
  • Merck KGaA
  • Nano-Ditech Corp.
  • Nexus Dx, Inc.
  • Nova Biomedical Corporation
  • Polymer Technology Systems, Inc. by Sinocare
  • Precision Biosensor, Inc.
  • QuidelOrtho Corporation
  • Sekisui Chemical Co., Ltd.
  • Siemens Healthineers AG
  • Werfen, SA
Product Code: MRR-02026C4CB4BE

The Cardiac POC Testing Devices Market was valued at USD 1.36 billion in 2023, expected to reach USD 1.52 billion in 2024, and is projected to grow at a CAGR of 12.36%, to USD 3.08 billion by 2030.

Cardiac Point-of-Care (POC) testing devices are portable medical diagnostic tools designed for quick and accurate assessment of cardiac markers directly at the site of patient care, rather than relying on centralized laboratory facilities. These devices are crucial in emergencies to provide rapid test results, assisting healthcare providers in making timely decisions, such as in cases of acute myocardial infarction. Their application extends across various settings, including hospitals, clinics, ambulatory care, and even home healthcare, thanks to their ease of use and non-reliance on specialized laboratories. Market growth is predominantly influenced by the rising prevalence of cardiovascular diseases, the increasing demand for rapid diagnostic solutions, and a worldwide trend towards decentralized patient management. Innovations in biomarker discovery and microfluidics are driving technological advancements in this sector, further expanding its application scope, and providing lucrative opportunities for new entrants and existing players alike. However, challenges remain due to stringent regulatory requirements, high device costs, and issues related to testing accuracy and reliability in non-laboratory settings. Regions with a burgeoning demand for healthcare infrastructure, such as Asia-Pacific and Latin America, present significant potential for market penetration and growth. Moreover, collaborative R&D efforts focusing on device miniaturization and connectivity enhancements, such as integration with health IT systems, offer avenues for differentiation and market leadership. Companies should capitalize on digital health trends by developing connected POC solutions that support telemedicine and remote monitoring, thus aligning with evolving patient care models. A key area for innovation lies in enhancing the reliability and breadth of the test panel available on POC devices, enabling comprehensive and more precise cardiac diagnostics. Continuous investment in AI-driven analytics for predictive healthcare can further position players favorably in the competitive landscape.

KEY MARKET STATISTICS
Base Year [2023] USD 1.36 billion
Estimated Year [2024] USD 1.52 billion
Forecast Year [2030] USD 3.08 billion
CAGR (%) 12.36%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cardiac POC Testing Devices Market

The Cardiac POC Testing Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Prevalence of cardiac disorders and rising geriatric population globally
    • Inclination toward the early detection and diagnosis of patients
    • Favorable government support for cardiac health
  • Market Restraints
    • Potential risk of product recall in Cardiac POC testing devices
  • Market Opportunities
    • Implementation of unique & new troponin-based test
    • Positive investment and startup ecosystem
  • Market Challenges
    • Limitations and concerns associated with the accuracy of cardiac POC testing devices

Porter's Five Forces: A Strategic Tool for Navigating the Cardiac POC Testing Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cardiac POC Testing Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cardiac POC Testing Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cardiac POC Testing Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cardiac POC Testing Devices Market

A detailed market share analysis in the Cardiac POC Testing Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cardiac POC Testing Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cardiac POC Testing Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cardiac POC Testing Devices Market

A strategic analysis of the Cardiac POC Testing Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cardiac POC Testing Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, ACON Laboratories, Inc., Alfa Scientific Designs, Inc., Bio-Rad Laboratories, Inc., Cipla Limited, Compagnie Merieux Alliance SAS, Danaher Corporation, F. Hoffmann-La Roche Ltd, Getein Biotech, Inc., Laboratory Corporation of America Holdings, LifeSign LLC, Medtronic plc, Merck KGaA, Nano-Ditech Corp., Nexus Dx, Inc., Nova Biomedical Corporation, Polymer Technology Systems, Inc. by Sinocare, Precision Biosensor, Inc., QuidelOrtho Corporation, Sekisui Chemical Co., Ltd., Siemens Healthineers AG, and Werfen, S.A..

Market Segmentation & Coverage

This research report categorizes the Cardiac POC Testing Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Cardiac Biomarker Test, Consumable & Accessories, and Devices. The Cardiac Biomarker Test is further studied across B-Type Natriuretic Peptide, Creatine Kinase-MB [CK-MB] Fraction, D-dimer Tests, Myoglobin Tests, and Troponin Tests. The Devices is further studied across Analyzers and Imaging & Monitoring Devices.
  • Based on Device Type, market is studied across Bench-top POC Devices, Handheld POC Devices, and Wearable POC Devices.
  • Based on Application, market is studied across Diagnostics & Screening and Monitoring.
  • Based on End-User, market is studied across Ambulatory Surgical Centers, Diagnostic Laboratories, Home Settings, and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Prevalence of cardiac disorders and rising geriatric population globally
      • 5.1.1.2. Inclination toward the early detection and diagnosis of patients
      • 5.1.1.3. Favorable government support for cardiac health
    • 5.1.2. Restraints
      • 5.1.2.1. Potential risk of product recall in Cardiac POC testing devices
    • 5.1.3. Opportunities
      • 5.1.3.1. Implementation of unique & new troponin-based test
      • 5.1.3.2. Positive investment and startup ecosystem
    • 5.1.4. Challenges
      • 5.1.4.1. Limitations and concerns associated with the accuracy of cardiac POC testing devices
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Favorable regulatory approvals for various cardiac POC testing devices
    • 5.2.2. Device Type: Exploration of wearable POC devices to provide convenient homecare for managing heart conditions
    • 5.2.3. Application: Critical role played by effective diagnostics & screening procedures in the management of cardiac diseases
    • 5.2.4. End-User: Extensive and comprehensive care provided by hospitals for improving cardiac health
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Cardiac POC Testing Devices Market, by Product

  • 6.1. Introduction
  • 6.2. Cardiac Biomarker Test
    • 6.2.1. B-Type Natriuretic Peptide
    • 6.2.2. Creatine Kinase-MB [CK-MB] Fraction
    • 6.2.3. D-dimer Tests
    • 6.2.4. Myoglobin Tests
    • 6.2.5. Troponin Tests
  • 6.3. Consumable & Accessories
  • 6.4. Devices
    • 6.4.1. Analyzers
    • 6.4.2. Imaging & Monitoring Devices

7. Cardiac POC Testing Devices Market, by Device Type

  • 7.1. Introduction
  • 7.2. Bench-top POC Devices
  • 7.3. Handheld POC Devices
  • 7.4. Wearable POC Devices

8. Cardiac POC Testing Devices Market, by Application

  • 8.1. Introduction
  • 8.2. Diagnostics & Screening
  • 8.3. Monitoring

9. Cardiac POC Testing Devices Market, by End-User

  • 9.1. Introduction
  • 9.2. Ambulatory Surgical Centers
  • 9.3. Diagnostic Laboratories
  • 9.4. Home Settings
  • 9.5. Hospitals

10. Americas Cardiac POC Testing Devices Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Cardiac POC Testing Devices Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Cardiac POC Testing Devices Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Siemens Healthineers launches NT-proBNPII assay on Atellica platform to enhance heart failure diagnosis and speed patient care
    • 13.3.2. F. Hoffmann-La Roche AG launches NT-proBNP point-of-care test on cobas h 232 to enhance early detection and management of CVD and heart failure in diabetes patients
    • 13.3.3. Analytics for Life and CorVista Health receive FDA clearance for non-invasive CorVista System with Pulmonary Hypertension
    • 13.3.4. Eko Health, Inc. and Mayo Clinic secure FDA clearance for AI-driven low ejection fraction detection
    • 13.3.5. SpinChip Diagnostics receives NOK 115 million investment from bioMerieux to commercialize next-generation cardiac POC testing devices
    • 13.3.6. Roche to acquire LumiraDx's microfluidic point-of-care technology to advance cardiovascular diagnostics
    • 13.3.7. Primary Healthtech's Mobilab device offers early detection of heart and chronic diseases with IoT integration
    • 13.3.8. EDX Medical Group Plc. acquires Hutano Diagnostics Ltd. to develop advanced smartphone-integrated POC tests
    • 13.3.9. EDX Medical Group acquires Hutano Diagnostics to revolutionize rapid healthcare tests with advanced diagnostic technology enhancing speed, accuracy, and cost-effectiveness
    • 13.3.10. Cipla launches cippoint, POC testing device to expand diagnostics portfolio with CE IVD approval, enhancing rapid clinical decision-making and market penetration
  • 13.4. Strategy Analysis & Recommendation
    • 13.4.1. F. Hoffmann-La Roche Ltd.
    • 13.4.2. Siemens Healthineers AG
    • 13.4.3. Abbott Laboratories
    • 13.4.4. Danaher Corporation
    • 13.4.5. Werfen, S.A.

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. ACON Laboratories, Inc.
  • 3. Alfa Scientific Designs, Inc.
  • 4. Bio-Rad Laboratories, Inc.
  • 5. Cipla Limited
  • 6. Compagnie Merieux Alliance SAS
  • 7. Danaher Corporation
  • 8. F. Hoffmann-La Roche Ltd
  • 9. Getein Biotech, Inc.
  • 10. Laboratory Corporation of America Holdings
  • 11. LifeSign LLC
  • 12. Medtronic plc
  • 13. Merck KGaA
  • 14. Nano-Ditech Corp.
  • 15. Nexus Dx, Inc.
  • 16. Nova Biomedical Corporation
  • 17. Polymer Technology Systems, Inc. by Sinocare
  • 18. Precision Biosensor, Inc.
  • 19. QuidelOrtho Corporation
  • 20. Sekisui Chemical Co., Ltd.
  • 21. Siemens Healthineers AG
  • 22. Werfen, S.A.

LIST OF FIGURES

  • FIGURE 1. CARDIAC POC TESTING DEVICES MARKET RESEARCH PROCESS
  • FIGURE 2. CARDIAC POC TESTING DEVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, 2018-2030 (USD THOUSAND)
  • FIGURE 4. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 5. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 6. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 8. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 10. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 12. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 14. AMERICAS CARDIAC POC TESTING DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS CARDIAC POC TESTING DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 16. UNITED STATES CARDIAC POC TESTING DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES CARDIAC POC TESTING DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 18. ASIA-PACIFIC CARDIAC POC TESTING DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC CARDIAC POC TESTING DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CARDIAC POC TESTING DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CARDIAC POC TESTING DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 22. CARDIAC POC TESTING DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. CARDIAC POC TESTING DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CARDIAC POC TESTING DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, 2018-2030 (USD THOUSAND)
  • TABLE 4. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 5. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
  • TABLE 6. CARDIAC POC TESTING DEVICES MARKET DYNAMICS
  • TABLE 7. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 8. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 9. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY B-TYPE NATRIURETIC PEPTIDE, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 10. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY CREATINE KINASE-MB [CK-MB] FRACTION, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 11. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY D-DIMER TESTS, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 12. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY MYOGLOBIN TESTS, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 13. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY TROPONIN TESTS, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 14. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 15. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY CONSUMABLE & ACCESSORIES, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 16. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 17. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY ANALYZERS, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 18. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY IMAGING & MONITORING DEVICES, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 19. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 20. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 21. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY BENCH-TOP POC DEVICES, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 22. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY HANDHELD POC DEVICES, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 23. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY WEARABLE POC DEVICES, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 24. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 25. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY DIAGNOSTICS & SCREENING, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 26. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY MONITORING, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 27. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 28. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 29. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 30. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY HOME SETTINGS, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 31. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 32. AMERICAS CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 33. AMERICAS CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 34. AMERICAS CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 35. AMERICAS CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 36. AMERICAS CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 37. AMERICAS CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 38. AMERICAS CARDIAC POC TESTING DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
  • TABLE 39. ARGENTINA CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 40. ARGENTINA CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 41. ARGENTINA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 42. ARGENTINA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 43. ARGENTINA CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 44. ARGENTINA CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 45. BRAZIL CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 46. BRAZIL CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 47. BRAZIL CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 48. BRAZIL CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 49. BRAZIL CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 50. BRAZIL CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 51. CANADA CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 52. CANADA CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 53. CANADA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 54. CANADA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 55. CANADA CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 56. CANADA CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 57. MEXICO CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 58. MEXICO CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 59. MEXICO CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 60. MEXICO CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 61. MEXICO CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 62. MEXICO CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 63. UNITED STATES CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 64. UNITED STATES CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 65. UNITED STATES CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 66. UNITED STATES CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 67. UNITED STATES CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 68. UNITED STATES CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 69. UNITED STATES CARDIAC POC TESTING DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD THOUSAND)
  • TABLE 70. ASIA-PACIFIC CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 71. ASIA-PACIFIC CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 72. ASIA-PACIFIC CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 73. ASIA-PACIFIC CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 74. ASIA-PACIFIC CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 75. ASIA-PACIFIC CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 76. ASIA-PACIFIC CARDIAC POC TESTING DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
  • TABLE 77. AUSTRALIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 78. AUSTRALIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 79. AUSTRALIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 80. AUSTRALIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 81. AUSTRALIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 82. AUSTRALIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 83. CHINA CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 84. CHINA CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 85. CHINA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 86. CHINA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 87. CHINA CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 88. CHINA CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 89. INDIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 90. INDIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 91. INDIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 92. INDIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 93. INDIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 94. INDIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 95. INDONESIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 96. INDONESIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 97. INDONESIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 98. INDONESIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 99. INDONESIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 100. INDONESIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 101. JAPAN CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 102. JAPAN CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 103. JAPAN CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 104. JAPAN CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 105. JAPAN CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 106. JAPAN CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 107. MALAYSIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 108. MALAYSIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 109. MALAYSIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 110. MALAYSIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 111. MALAYSIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 112. MALAYSIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 113. PHILIPPINES CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 114. PHILIPPINES CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 115. PHILIPPINES CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 116. PHILIPPINES CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 117. PHILIPPINES CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 118. PHILIPPINES CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 119. SINGAPORE CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 120. SINGAPORE CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 121. SINGAPORE CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 122. SINGAPORE CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 123. SINGAPORE CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 124. SINGAPORE CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 125. SOUTH KOREA CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 126. SOUTH KOREA CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 127. SOUTH KOREA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 128. SOUTH KOREA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 129. SOUTH KOREA CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 130. SOUTH KOREA CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 131. TAIWAN CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 132. TAIWAN CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 133. TAIWAN CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 134. TAIWAN CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 135. TAIWAN CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 136. TAIWAN CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 137. THAILAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 138. THAILAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 139. THAILAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 140. THAILAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 141. THAILAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 142. THAILAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 143. VIETNAM CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 144. VIETNAM CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 145. VIETNAM CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 146. VIETNAM CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 147. VIETNAM CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 148. VIETNAM CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA CARDIAC POC TESTING DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
  • TABLE 156. DENMARK CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 157. DENMARK CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 158. DENMARK CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 159. DENMARK CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 160. DENMARK CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 161. DENMARK CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 162. EGYPT CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 163. EGYPT CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 164. EGYPT CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 165. EGYPT CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 166. EGYPT CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 167. EGYPT CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 168. FINLAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 169. FINLAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 170. FINLAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 171. FINLAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 172. FINLAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 173. FINLAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 174. FRANCE CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 175. FRANCE CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 176. FRANCE CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 177. FRANCE CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 178. FRANCE CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 179. FRANCE CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 180. GERMANY CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 181. GERMANY CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 182. GERMANY CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 183. GERMANY CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 184. GERMANY CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 185. GERMANY CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 186. ISRAEL CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 187. ISRAEL CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 188. ISRAEL CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 189. ISRAEL CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 190. ISRAEL CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 191. ISRAEL CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 192. ITALY CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 193. ITALY CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 194. ITALY CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 195. ITALY CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 196. ITALY CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 197. ITALY CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 198. NETHERLANDS CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 199. NETHERLANDS CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 200. NETHERLANDS CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 201. NETHERLANDS CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 202. NETHERLANDS CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 203. NETHERLANDS CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 204. NIGERIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 205. NIGERIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 206. NIGERIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 207. NIGERIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 208. NIGERIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 209. NIGERIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 210. NORWAY CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 211. NORWAY CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 212. NORWAY CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 213. NORWAY CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 214. NORWAY CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 215. NORWAY CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 216. POLAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 217. POLAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 218. POLAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 219. POLAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 220. POLAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 221. POLAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 222. QATAR CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 223. QATAR CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 224. QATAR CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 225. QATAR CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 226. QATAR CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 227. QATAR CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 228. RUSSIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 229. RUSSIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 230. RUSSIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 231. RUSSIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 232. RUSSIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 233. RUSSIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 234. SAUDI ARABIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 235. SAUDI ARABIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 236. SAUDI ARABIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 237. SAUDI ARABIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 238. SAUDI ARABIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 239. SAUDI ARABIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 240. SOUTH AFRICA CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 241. SOUTH AFRICA CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 242. SOUTH AFRICA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 243. SOUTH AFRICA CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 244. SOUTH AFRICA CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 245. SOUTH AFRICA CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 246. SPAIN CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 247. SPAIN CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 248. SPAIN CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 249. SPAIN CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 250. SPAIN CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 251. SPAIN CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 252. SWEDEN CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 253. SWEDEN CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 254. SWEDEN CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 255. SWEDEN CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 256. SWEDEN CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 257. SWEDEN CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 258. SWITZERLAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 259. SWITZERLAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 260. SWITZERLAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 261. SWITZERLAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 262. SWITZERLAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 263. SWITZERLAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 264. TURKEY CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 265. TURKEY CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 266. TURKEY CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 267. TURKEY CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 268. TURKEY CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 269. TURKEY CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 270. UNITED ARAB EMIRATES CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 271. UNITED ARAB EMIRATES CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 272. UNITED ARAB EMIRATES CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 273. UNITED ARAB EMIRATES CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 274. UNITED ARAB EMIRATES CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 275. UNITED ARAB EMIRATES CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 276. UNITED KINGDOM CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 277. UNITED KINGDOM CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC BIOMARKER TEST, 2018-2030 (USD THOUSAND)
  • TABLE 278. UNITED KINGDOM CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICES, 2018-2030 (USD THOUSAND)
  • TABLE 279. UNITED KINGDOM CARDIAC POC TESTING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD THOUSAND)
  • TABLE 280. UNITED KINGDOM CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 281. UNITED KINGDOM CARDIAC POC TESTING DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 282. CARDIAC POC TESTING DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 283. CARDIAC POC TESTING DEVICES MARKET, FPNV POSITIONING MATRIX, 2023